| Code | CSB-RA011050MB3HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to Indemakitug, targeting interferon gamma (IFNG), a critical cytokine central to immune regulation and host defense. IFNG is primarily produced by activated T cells and natural killer cells and serves as a key mediator of both innate and adaptive immunity. It plays essential roles in macrophage activation, antigen presentation, and antimicrobial responses. Dysregulated IFNG signaling is implicated in various pathological conditions, including autoimmune diseases such as atopic dermatitis, inflammatory bowel disease, and systemic lupus erythematosus, as well as complications in transplant rejection and certain infectious diseases.
Indemakitug is a therapeutic antibody developed to neutralize IFNG activity and has been investigated in clinical trials for conditions involving excessive type 2 inflammation and aberrant immune responses. This biosimilar antibody provides researchers with a valuable tool for investigating IFNG-mediated pathways, studying immune dysregulation mechanisms, and exploring potential therapeutic interventions in inflammation-driven disorders.
There are currently no reviews for this product.